This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WebMD Health CEO Discusses Q2 2012 Results - Earnings Call Transcript

To every step of healthy living and a longer patient’s journey, WebMD is helping consumers understand symptoms prepare for the doctor’s visit and learn about diagnosis, evaluation of treatment options and living with conditions. Medscape is the go-to brand for physicians and healthcare providers. Medscape demonstrates and Medscape generates substantially more physician engagement than any other health professional site. Doctors are searching for information on our latest treatments, best practices and latest news.

They are checking daily news in their specialty, reading journals, conference coverage and interacting with their peers and key opinion leaders in order to have a conversation about their field of medicine. They are checking dosing interactions and other important information as they are writing prescriptions patient encounters. Whether it's at the point of care in their office for during their daily commute or at home, Medscape is integral to a physician’s daily practice of medicine and their continuing education.

WebMD and Medscape are the go-to brands because we have an outstanding publishing engine and a world class technology organization. WebMD is the industry’s first and only optimized multiscreen experience empowering and enabling healthcare decisions anytime and anywhere.

So why are our revenues declining and what are we going to do about it? This is the key question in the short term in order to build the long term. There are two key factors impacting our revenue trend, first externally, we are operating in a challenging and changing marketplace, second, internally we must look closely at our go-to market strategy and our commercial offerings in our key customer segments and markets.

Let’s first look externally at the industry, WebMD’s primary source of revenue has been large biopharmaceutical companies followed by large consumer product companies. So what is happening in their business is affecting ours, our customers are under pressure, under pressure to grow and under pressure for cost containment. Biopharmas growth is largely reliant by new product launches to replace the estimated 72 billion in product sales that will lose exclusivity by 2015. In fact, in 2012, Biopharma will see 31 billion from branded to generics through the patent expiration.

Read the rest of this transcript for free on seekingalpha.com

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs